The rapidly evolving healthcare landscape is placing increased emphasis on early disease detection and targeted therapy, catalyzing growth in diagnostic technologies worldwide. A standout in this space is the Cardiac Biomarker Testing Market Share, which has witnessed substantial expansion owing to the rising global prevalence of cardiovascular diseases (CVDs), technological innovations in bioma..